Surgery Partners (SGRY) EBIT (2014 - 2026)

Surgery Partners has disclosed EBIT across 13 years of filings, most recently posting $102.1 million for Q2 2026.

• In Q2 2026, EBIT fell 8.59% year-over-year to $102.1 million; the TTM figure through Jun 2026 stood at $383.8 million (up 6.14% YoY), while the FY2025 annual figure was $389.5 million, up 11.67% from the prior year.
• EBIT came in at $102.1 million for Q2 2026 at Surgery Partners, up from $65.8 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $127.1 million in Q4 2024 to a low of $46.4 million in Q1 2023.
• Average EBIT over 5 years is $87.7 million, with a median of $89.5 million recorded in 2022.
• Year-over-year, EBIT slumped 53.78% in 2023 and soared 73.56% in 2025.
• Over 5 years, EBIT stood at $94.2 million in 2022, then rose by 7.64% to $101.4 million in 2023, then advanced by 25.35% to $127.1 million in 2024, then retreated by 13.3% to $110.2 million in 2025, then retreated by 7.35% to $102.1 million in 2026.
• Per Business Quant data, the three most recent EBIT figures were $102.1 million in Q2 2026, $65.8 million in Q1 2026, and $110.2 million in Q4 2025.